David M. Knott’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

David M. Knott’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-109,135	Closed	-$77K	–	131
2019 Q4	$77K	Hold	109,135	–	–	0.03%	99
2019 Q3	$79K	Hold	109,135	–	–	0.03%	99
2019 Q2	$85K	Hold	109,135	–	–	0.04%	92
2019 Q1	$134K	Hold	109,135	–	–	0.05%	82
2018 Q4	$92K	Sell	109,135 -49	-0%	-$55	0.04%	83
2018 Q3	$323K	Hold	109,184	–	–	0.1%	72
2018 Q2	$402K	Hold	109,184	–	–	0.15%	69
2018 Q1	$382K	Hold	109,184	–	–	0.16%	69
2017 Q4	$341K	Hold	109,184	–	–	0.14%	70
2017 Q3	$768K	Hold	109,184	–	–	0.33%	38
2017 Q2	$1.01M	Hold	109,184	–	–	0.42%	22
2017 Q1	$1.17M	Hold	109,184	–	–	0.56%	16
2016 Q4	$919K	Buy	+109,184	New	+$967K	0.46%	21

David M. Knott's NVLN Position: Q1 2020 in Review

David M. Knott sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q1 2020, closing a stake of 109,135 shares — an estimated $77K sold.

David M. Knott first reported a position in NVLN in Q4 2016 and held it in 13 quarters. The position peaked at $1.17M in Q1 2017. 1 fund tracked by Wall St. Rank holds NVLN as of Q1 2020.

David M. Knott reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q1 2020 after selling out during the quarter.
David M. Knott sold 109,135 Novelion Therapeutics Inc. Common Shares shares in Q1 2020, an estimated $77K.
David M. Knott first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 13 quarters.
David M. Knott's Novelion Therapeutics Inc. Common Shares position peaked at $1.17M in Q1 2017.
1 fund tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q1 2020.

Based on David M. Knott's 13F filing for Q1 2020, filed 13 May 2020.